And it looks like Johnson & Johnson (NYSE: JNJ) just hit a bump in the road that'll pave the way for Eli Lilly (NYSE: LLY) to ...

Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...

FDA-approved drugs can be compounded under certain ... state and local regulatory guidelines”. Also involved in Eli Lilly’s most recent filing, were Pivotal Peptides and Genesis Lifestyle ...

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...

The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy Kisunla today, but the drug is too expensive to ...

In its most recent filings ... to an unjustifiable risk of harm." Eli Lilly is seeking court orders barring the vendors from selling their drugs that say they contain tirzepatide and unspecified ...

Eli Lilly said on Monday ... since the U.S. Food and Drug Administration took the drug off its list of medicines in short supply earlier this month. Lilly said these lawsuits were not contingent ...

In its most recent filings ... to an unjustifiable risk of harm." Eli Lilly is seeking court orders barring the vendors from selling their drugs claiming to contain tirzepatide and unspecified ...

MangoRx was responding to Eli Lily after the drugmaker sued it and two other medical spas and online vendors earlier this ...

First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...

Eli Lilly and Company, Novo Nordisk A/S, Roche Holding Ltd ADR, Structure Therapeutics Inc ADR. Read MarketBeat.com (Leo Miller)'s latest article on Investing.com ...